These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2414920)

  • 1. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site.
    Najjar JA; Gentsch JR; Nathanson N; Gonzalez-Scarano F
    Virology; 1985 Jul; 144(2):426-32. PubMed ID: 2414920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
    Grady LJ; Sanders ML; Campbell WP
    Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.
    Kingsford L; Ishizawa LD; Hill DW
    Virology; 1983 Sep; 129(2):443-55. PubMed ID: 6194614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against La Crosse virus.
    Grady LJ; Srihongse S; Grayson MA; Deibel R
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
    Kingsford L; Boucquey KH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses.
    Gonzalez-Scarano F; Shope RE; Calisher CH; Nathanson N
    Prog Clin Biol Res; 1983; 123():145-56. PubMed ID: 6191341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein.
    Kingsford L
    Virology; 1984 Jul; 136(2):265-73. PubMed ID: 6205500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and biological function of La Crosse G1 glycoprotein.
    Kingsford L
    Prog Clin Biol Res; 1983; 123():157-66. PubMed ID: 6191342
    [No Abstract]   [Full Text] [Related]  

  • 10. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition.
    Heinz FX; Berger R; Tuma W; Kunz C
    Virology; 1983 Oct; 130(2):485-501. PubMed ID: 6196909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid diagnosis of La Crosse virus infections: evaluation of serologic and antigen detection techniques for the clinically relevant diagnosis of La Crosse encephalitis.
    Beaty BJ; Jamnback TL; Hildreth SW; Brown KL
    Prog Clin Biol Res; 1983; 123():293-302. PubMed ID: 6346337
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
    Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.
    van Wyke Coelingh K; Tierney EL
    J Virol; 1989 Jan; 63(1):375-82. PubMed ID: 2462062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus.
    Sundin DR; Beaty BJ; Nathanson N; Gonzalez-Scarano F
    Science; 1987 Jan; 235(4788):591-3. PubMed ID: 3810159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses.
    Gonzalez-Scarano F; Shope RE; Calisher CE; Nathanson N
    Virology; 1982 Jul; 120(1):42-53. PubMed ID: 7101727
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).
    Montalvo EA; Grose C
    Virology; 1986 Mar; 149(2):230-41. PubMed ID: 2418586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies directed against the envelope glycoproteins of La Crosse virus.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Microb Pathog; 1991 Dec; 11(6):411-21. PubMed ID: 1795631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
    Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
    Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.